RRE Ventures Acquisition Corp.·4

May 5, 4:30 PM ET

Epstein Jeffrey Douglas 4

Research Summary

AI-generated summary

Updated

RRE Ventures (RREV) President Jeffrey D. Epstein Receives Awards

What Happened

  • Jeffrey Douglas Epstein, President and Director of RRE Ventures Acquisition Corp. (RREV), reported three awards/acquisitions of derivative securities. He was granted 450,000 units on 2026-03-02 and 150,000 units on 2026-03-18 at $0.00 each (no cash paid), and a 500,000-unit award on 2026-05-01 at $1.00 each (total cash value $500,000). All reported transactions are classified as derivative securities (awards), not open-market purchases or sales.

Key Details

  • Transaction dates and prices:
    • 2026-03-02: 450,000 units @ $0.00 (award)
    • 2026-03-18: 150,000 units @ $0.00 (award)
    • 2026-05-01: 500,000 units @ $1.00 (award) — $500,000 total
  • Total units acquired (all awards): 1,100,000
  • Shares owned after transactions: Not specified in the provided excerpt of the filing.
  • Footnotes of note:
    • F1: Class B ordinary shares convert one-for-one into Class A ordinary shares at the issuer's initial business combination (or earlier at the holder’s option) and have no expiration date.
    • F2: Some of these securities were previously reported on the Reporting Person’s Form 3.
    • F3: Private placement warrants (if applicable to these awards) become exercisable 30 days after the initial business combination and expire five years after that event (or earlier upon liquidation).
  • Timeliness: The Form 4 was filed on 2026-05-05. The March 2 and March 18 awards were reported late (filed well after the 2-business-day rule); the May 1 award appears to have been filed within the usual 2-business-day window.

Context

  • These are derivative awards (convertible Class B shares and/or private placement warrants), not immediate sales. Class B shares typically convert into publicly traded Class A shares only upon the SPAC’s business combination; warrants typically have an exercise window that begins after that combination. Awards and grants are generally different from open-market purchases or sales and can reflect compensation, retention, or alignment with shareholders rather than direct market timing.
  • The late reporting of the March grants reduces near-term transparency; the SEC allows a short window for Form 4 filings and late reports can draw attention but do not by themselves indicate wrongdoing.